مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

97
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

80
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line

Pages

  63-68

Abstract

 Purpose: Human Hepatocellular carcinoma is one of the most common causes of death in the world. Metformin and Rapamycin may decrease the expression of VEGF protein and subsequently angiogenesis. The purpose of this study was to evaluate the effect of these two drugs on expression of VEGF protein and the cell proliferation in the Hepatocellular carcinoma cell line (ATCC HB-8065). Methods: HepG2 was cultured in RPMI-1640 medium at 37° C for 48h as a pre-culture and then treated by different concentrations of Metformin (0, 5, 10 and 20 mM) and Rapamycin (0, 5, 10 and 20 nM) at different times (12, 24 and 48 h). Cell viability was assessed by the MTT assay. Total RNA was extracted by the Trizol reagent and VEGF gene expression was analyzed by quantitative real-time PCR and was calculated by 2– Δ Ct method. The VEGF protein level was determined by Elisa assay. Finally, Apoptosis index was calculated by DAPI staining. Results: Metformin and Rapamycin significantly decrease cancer cells viability (p<0. 05). Rapamycin but not Metformin decreases VEGF gene expression in HepG2 cells. Metformin and Rapamycin significantly induce cell apoptosis in Hepatocellular carcinoma (HCC) cells. Conclusion: Metformin and Rapamycin have an anti-tumor effect on HCC. According to our data Rapamycin might have an anti-angiogenesis effect via inhibition of VEGF expression. Our results provide an insight into future clinical strategies to improve chemotherapy outcomes in HCC.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    Rastegar, Mandana, Marjani, Haji Amin, YAZDANI, YAGHOUB, SHAHBAZI, MAJID, GOLALIPOUR, MASOUD, & FARAZMANDFAR, TOURAJ. (2018). Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line. ADVANCED PHARMACEUTICAL BULLETIN, 8(1), 63-68. SID. https://sid.ir/paper/745741/en

    Vancouver: Copy

    Rastegar Mandana, Marjani Haji Amin, YAZDANI YAGHOUB, SHAHBAZI MAJID, GOLALIPOUR MASOUD, FARAZMANDFAR TOURAJ. Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line. ADVANCED PHARMACEUTICAL BULLETIN[Internet]. 2018;8(1):63-68. Available from: https://sid.ir/paper/745741/en

    IEEE: Copy

    Mandana Rastegar, Haji Amin Marjani, YAGHOUB YAZDANI, MAJID SHAHBAZI, MASOUD GOLALIPOUR, and TOURAJ FARAZMANDFAR, “Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line,” ADVANCED PHARMACEUTICAL BULLETIN, vol. 8, no. 1, pp. 63–68, 2018, [Online]. Available: https://sid.ir/paper/745741/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button